Hilfe beim Zugang

Haben Sie den VPN-Client gestartet bzw. sind Sie via Shibboleth angemeldet (weitere Informationen)?

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

Abstract Background Several phase 3 studies reported positive results for combinations of Immune-Oncology (IO) and Vascular Endothelial Growth Factor (VEGF) targeted therapies in patients with metastatic clear cell Renal Cell Carcinoma (ccRCC). However, there are limited data on outcomes to systemic...
Ausführliche Beschreibung